Elaine Phillips's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
Elaine Phillips
President and General Manager
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
15
Since Nov 2021
15
Active registrations
0
Dec 2024 Reports per month Nov 2026
Reported meetings
Justine Frame · Policy Advisor, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Abla Hanna · Director of Operations, Natural Resources Canada (NRCan)
Isabelle Mondou · Deputy Clerk, Privy Council Office (PCO)
Greg Reade · Assistant Secretary to the Cabinet, Privy Council Office (PCO)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Jade Mallette · Chief of Staff to the Minister of Health, Health Canada (HC)
Justine Frame · Policy Advisor, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Marie-Pier Fontaine · Deputy Director, Privy Council Office (PCO)
Kathleen McLellan · Senior Policy Advisor, Privy Council Office (PCO)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Marjorie Michel · Minister of Health
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Kaili Levesque · Associate Deputy Minister, Fisheries and Oceans Canada (DFO)
and 9 more Show fewer
Supriya Sharma · Acting ADM, Innovation, Science and Economic Development Canada (ISED)
Nasser Haidar · Senior Policy Advisor, Intergovernmental Affairs Secretariat (IGA)
Elizabeth Wong · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Annahat Koshar · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Fatoumata Bah · Policy Advisor, Health Canada (HC)
Scott Lohnes · Senior Advisor, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Kaili Levesque · Associate Deputy Minister, Fisheries and Oceans Canada (DFO)
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
Elizabeth Wong · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
and 6 more Show fewer
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Justine Frame · Policy Advisor, Health Canada (HC)
Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Linsey Hollett · Assistant Deputy Minister, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Kaili Levesque · ADM, Innovation, Science and Economic Development Canada (ISED)
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
and 6 more Show fewer
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Justine Frame · Policy Advisor, Health Canada (HC)
Jibril Hussein · Senior Policy Advisor, Health Canada (HC)
Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Linsey Hollett · Assistant Deputy Minister, Health Canada (HC)
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
Linsey Hollett · Assistant Deputy Minister, Health Canada (HC)
and 3 more Show fewer
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Justine Frame · Policy Advisor, Health Canada (HC)
Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Sony Perron · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Elizabeth Wong · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
and 5 more Show fewer
Celia Lourenco · AADM, Health Canada (HC)
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Pamela Aung-Thin · Assistant Deputy Minister, Health Canada (HC)
Justine Frame · Policy Advisor, Health Canada (HC)
Sara O'Connor · AADM, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Maggie Chi · Member of Parliament
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Elizabeth Wong · Senior Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
and 8 more Show fewer
Nasser Haidar · Senior Policy Advisor, Intergovernmental Affairs Secretariat (IGA)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Annahat Kochar · Policy Advisor, Treasury Board Of Canada Secretariat (TBS)
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Justine Frame · Policy Advisor, Health Canada (HC)
Pamela Aung-Thin · Assistant Deputy Minister, Health, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Sony Perron · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
and 2 more Show fewer
Daniel MacDonald · Director General, Health Canada (HC)
Brent Lawlor · Acting Director, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Justine Frame · Policy Advisor, Health Canada (HC)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
Nasser Haidar · Senior Policy Advisor, Intergovernmental Affairs Secretariat (IGA)
Galen Richardson · Senior Advisor, Stakeholder Relations, Privy Council Office (PCO)
C-6444-1
Bill C-64 (Pharmacare Act - 2024)
Patented Medicine Prices Review Board (PMPRB) Reform
Most Favored Nation
National Pharmacare
Drugs for Rare Diseases
Official report
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.